We are live on
!
Find out more
TM
Triatomic Management Portfolio holdings
AUM
$3.39M
1-Year Est. Return
3.35%
This Fund
S&P 500
This Quarter
Est. Return
-6.53%
1 Year Est. Return
-3.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$55.1M
(-32%)
Cap. Flow
-$49.9M
Cap. Flow
% of AUM
-41.98%
Top 10 Holdings %
Top 10 Hldgs %
76.19%
Holding
68
New
17
Increased
7
Reduced
9
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centrus Energy
LEU
|
+$1.97M |
| 2 |
AGNT
AGNT Inc
AGNT
|
+$1.37M |
| 3 |
Lemonade
LMND
|
+$989K |
| 4 |
Intellia Therapeutics
NTLA
|
+$951K |
| 5 |
monday.com
MNDY
|
+$624K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twilio
TWLO
|
+$2.23M |
| 2 |
Lyft
LYFT
|
+$1.98M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.75M |
| 4 |
KE Holdings
BEKE
|
+$1.74M |
| 5 |
Adaptive Biotechnologies
ADPT
|
+$1.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.52% |
| 2 | Technology | 4.45% |
| 3 | Consumer Discretionary | 3.07% |
| 4 | Energy | 1.41% |
| 5 | Real Estate | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Intellia Therapeutics
NTLA
$1.5B
| $698K | 0.59% |
+20,000
| New | +$951K |
|
|
27
CALL
Adaptive Biotechnologies
ADPT
$3.52B
| $611K | 0.51% |
+80,000
| New | +$622K |
|
28
Gaotu Techedu
GOTU
$374M
| $554K | 0.47% |
234,590
| – | – |
|
29
Zai Lab
ZLAB
$2.18B
| $544K | 0.46% |
17,710
-31,893
| -64% | -$1.01M |
|
30
Micron Technology
MU
$1.03T
| $500K | 0.42% |
+10,000
| New | +$547K |
|
31
Beyond Meat
BYND
$286M
| $495K | 0.42% |
40,242
-4,985
| -11% | -$69.4K |
|
32
Aehr Test Systems
AEHR
$2.46B
| $492K | 0.41% |
+24,500
| New | +$524K |
|
33
NVIDIA
NVDA
$4.98T
| $438K | 0.37% |
30,000
| – | – |
|
34
Teladoc Health
TDOC
$1.59B
| $402K | 0.34% |
17,000
| – | – |
|
35
Advanced Micro Devices
AMD
$850B
| $389K | 0.33% |
6,000
| – | – |
|
36
Lucid Motors
LCID
$2.45B
| $376K | 0.32% |
5,500
-1,777
| -24% | -$196K |
|
37
Inovio Pharmaceuticals
INO
$80.1M
| $367K | 0.31% |
19,583
| – | – |
|
38
Rivian
RIVN
$22.9B
| $350K | 0.29% |
+19,000
| New | +$559K |
|
|
OMIC
39
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $312K | 0.26% |
5,180
-2,574
| -33% | -$173K |
|
40
Tesla
TSLA
$1.22T
| $246K | 0.21% |
+2,000
| New | +$379K |
|
|
DMTK
41
DELISTED
DermTech, Inc. Common Stock
DMTK
| $225K | 0.19% |
127,208
-104,357
| -45% | -$278K |
|
42
Senti Biosciences Holdings
SNTI
$12.7M
| $214K | 0.18% |
15,168
+9,523
| +169% | +$232K |
|
43
Lumen
LUMN
$6.52B
| $132K | 0.11% |
+25,200
| New | +$155K |
|
|
ME
44
DELISTED
23andMe Holding Co
ME
| $125K | 0.11% |
2,891
| – | – |
|
|
NKLA
45
DELISTED
Nikola Corporation Common Stock
NKLA
| $108K | 0.09% |
1,667
| – | – |
|
46
Nano X Imaging
NNOX
$62.7M
| $88.6K | 0.07% |
12,000
| – | – |
|
|
LOGC
47
DELISTED
ContextLogic
LOGC
| $48.8K | 0.04% |
3,333
| – | – |
|
48
Invivyd
IVVD
$180M
| $38.7K | 0.03% |
25,800
| – | – |
|
|
CMAXW
49
DELISTED
CareMax, Inc. Warrant
CMAXW
| $34K | 0.03% |
65,021
| – | – |
|
50
Newegg Commerce
NEGG
$300M
| $28.8K | 0.02% |
1,100
| – | – |
|
Similar funds
APGC
APA
SCG
AI
KSCM
SP
EL
T
Triatomic Management's Q4 2022 Portfolio in Review
As of Q4 2022, Triatomic Management held 68 positions worth $119M, down 32% from $174M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Triatomic Management withdrew a net $49.9M in Q4 2022, closing 18 positions and reducing 9 holdings. Its most notable exit was Twilio, an estimated $2.23M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Triatomic Management opened a new position in Centrus Energy worth $1.68M.
- Triatomic Management's largest Q4 2022 buy was Centrus Energy: 51,695 shares worth $1.68M.
- Triatomic Management added most to Lemonade in Q4 2022, an estimated $989K increase.
- Triatomic Management's biggest Q4 2022 reduction was Adaptive Biotechnologies, cutting an estimated $1.36M.
- Triatomic Management fully exited Twilio in Q4 2022, selling an estimated $2.23M.
- Triatomic Management's ten largest holdings make up 76% of its $119M portfolio in Q4 2022.
- Triatomic Management opened 17 new positions and closed 18 in Q4 2022.
- Triatomic Management's portfolio value fell 32% quarter-over-quarter to $119M.
Based on Triatomic Management's 13F filing for Q4 2022, filed 13 Feb 2023.